GCI Health’s London office has bolstered its senior leadership team with the hire of David Berkovitch, who joins after a four-year stint at 3 Monkeys Zeno and prev
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.